27:
147:. In 1952, the group was renamed as the Council for International Organizations of Medical Sciences (CIOMS) to reflect a focus on guiding member organizations that internally organize field-specific conferences. From 1967 to 1997, it organized annual round tables on medical science topics, offering a standardized conference format:
398:
349:
130:
The
General Assembly of all CIOMS member organizations meets every year, alternating between in-person and teleconference formats, to elect the Executive Committee and its voting President. The Executive Committee of twelve representatives from national and international member groups meets at least
242:
In 1990, CIOMS shifted to a format of assembling working groups of scientists from regulatory bodies, industry, and academia to meet for 2–4 years to reach consensus with other stakeholders and publish recommended guidelines. When the working groups are composed solely of CIOMS members, they are
575:
443:
364:
325:'s Statistical Research Unit, chaired a Vienna-based CIOMS conference on controlled clinical trials. The proceedings, published in 1960, commented on research ethics, experimental design, and statistical analysis. Hill would later outline "
403:
555:
590:
545:
131:
one a year, appointing and guiding the
Secretariat, consisting of the Secretary-General and their team in Geneva, Switzerland. The Executive Committee can invite non-voting ad hoc observers and technical experts.
413:
535:
99:) is an international non-governmental organization of 40 international, national, and associate member groups representing the biomedical science community. It was jointly established by the
560:
506:
393:
518:
482:
408:
550:
139:
After its 1948 founding by UNESCO and the WHO as the
Council for Coordination of International Medical Congresses, these UN specialized agencies funded its first conference in
565:
601:
476:
488:
801:
540:
428:
379:(HL7) used these guidelines in publishing the ISO/HL7 27953:2011 standards on Health Informatics: Individual Case Safety Reports (ICSRs) in Pharmacovigilance.
118:
The group's main goal is advancing public health by publishing guidelines on ethics, product development, and safety in medical research, such as the 2016
580:
368:
585:
530:
500:
418:
433:
172:
VIII. Protection of Human Rights in the Light of
Scientific and Technological Progress in Biology and Medicine, Geneva, Switzerland, 1973
423:
220:
XXIV. Genetics, Ethics, and Human Values: Human Genome
Mapping, Genetic Screening and Gene Therapy, Tokyo and Inuyama City, Japan, 1990
322:
713:
694:
949:
1111:
1092:
United
Nations Educational, Scientific and Cultural Organization (UNESCO) - Universal Declaration on Bioethics and Human Rights
570:
512:
372:
336:. These guidelines have been praised for including diverse stakeholders from low- and middle-income countries, compared to the
844:
758:
596:
616:
470:
464:
1091:
211:
XXI. Health Policy, Ethics, and Human Values: European and North
American Perspectives, Noordwijk, the Netherlands, 1987
494:
606:
611:
376:
286:
Working Group XI (founded April 2018): Patient
Involvement in the Development, Regulation and Safe Use of Medicines
199:
XVII. Biomedical
Research Involving Animals – Proposed International Guiding Principles, Geneva, Switzerland, 1983
1121:
648:
1086:
295:
Working Group XIII (founded March 2020): Real-World Data and Real-World
Evidence in Regulatory Decision Making*
108:
715:
243:
assigned a sequential identifier, whereas partnerships with outside groups are known by their specific topic:
714:
Council for International Organizations of Medical Sciences (CIOMS); World Health Organization (WHO) (2016).
232:
XXVIII. Poverty, Vulnerability, the Value of Human Life, and the Emergence of Bioethics, Ixtapa, Mexico, 1994
229:
XXVII. Drug Surveillance: International Cooperation – Past, Present, and Future, Geneva, Switzerland, 1993
954:
International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH)
365:
International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH)
831:. Interdisciplinary and International Research (1 ed.). Bristol University Press. pp. 86–100.
1106:
438:
256:
Working Group IV (founded 1998): Benefit-Risk Balance for Marketed Drugs: Evaluation of Safety Signals
169:
VII. Recent Progress in Biology and Medicine: Its Social and Ethical Implications, Paris, France, 1972
828:
Modes of Influence: What Can We Learn From International Codes of Ethics for Health-Related Research?
448:
341:
100:
880:
253:
Working Group III (founded 1995): Guidelines for Preparing Core Clinical-Safety Information on Drugs
756:
692:
196:
XVI. Health for All – A Challenge to Research in Health Manpower Development, Ibadan, Nigeria, 1982
298:
International Guidelines on Good Governance Practice for Research Institutions (founded July 2021)
1116:
399:
International Federation of Associations of Pharmaceutical Physicians and Pharmaceutical Medicine
337:
250:
Working Group II (founded 1992): International Reporting of Periodic Drug-Safety Update Summaries
226:
XXVI. Ethics and Research on Human Subjects. International Guidelines, Geneva, Switzerland, 1992
326:
332:
This publication laid the groundwork for CIOMS' 1982, 1993, 2002, 2009, and 2016 versions of
202:
XVIII. Health Policy Ethics and Human Values: An International Dialogue, Athens, Greece, 1984
353:
318:
8:
259:
Standardized Medical Dictionary for Regulatory Activities (MedDRA) Queries (founded 2002)
292:
Working Group XII (founded September 2019): Benefit-Risk Balance for Medicinal Products*
235:
The Declaration of Inuyama, a follow-up to the 1990 Conference, Inuyama and Nagayo, 1995
166:
VI. Drug Abuse: Non-Medical Use of Dependence-Producing Drugs, Geneva, Switzerland, 1971
931:
868:
850:
802:"The 1959 Meeting in Vienna on Controlled Clinical Trials – A Methodological Landmark"
923:
915:
911:
840:
825:
Busby, Helen (2022). "Modes of influence". In Iphofen, Ron; O’Mathúna, Dónal (eds.).
757:
Council for International Organizations of Medical Sciences (CIOMS) (11 April 2019).
638:
628:
345:
935:
329:" for establishing causal relationships between statistically correlated phenomena.
181:
XI. Trends and Prospects in Drug Research and Development, Geneva, Switzerland, 1977
907:
895:
832:
301:
Working Group XIV (founded May 2022): Artificial Intelligence in Pharmacovigilance*
217:
XXIII. Health Technology Transfer: Whose Responsibility? Geneva, Switzerland, 1989
208:
XX. Health Manpower out of Balance. Conflicts and Prospects, Acapulco, Mexico 1986
151:
I. Biomedical Science and the Dilemma of Human Experimentation Paris, France, 1967
247:
Working Group I (founded 1990): International Reporting of Adverse Drug Reactions
223:
XXV. Ethics and Epidemiology: International Guidelines, Geneva, Switzerland, 1990
178:
X. Health Needs of Society: A Challenge for Medical Education Ulm, Germany, 1976
160:
IV. Medical Research: Priorities and Responsibilities, Geneva, Switzerland, 1969
643:
950:"E2B(R3) Individual Case Safety Report (ICSR) Specification and Related Files"
854:
826:
184:
XII. Medical Ethics and the Protection of Human Rights Cascais, Portugal, 1978
163:
V. Training of Research Workers in Medical Sciences, Geneva, Switzerland, 1970
1100:
919:
716:
International Ethical Guidelines for Health-Related Research Involving Humans
334:
International Ethical Guidelines for Health-Related Research Involving Humans
120:
International Ethical Guidelines for Health-Related Research Involving Humans
693:
Council for International Organizations of Medical Sciences (CIOMS) (1995).
927:
836:
576:
International Society of Hepatic Encephalopathies & Nitrogen Metabolism
775:
214:
XXII. Ethics and Human Values in Family Planning, Bangkok, Thailand, 1988
112:
105:
United Nations Educational, Scientific and Cultural Organization (UNESCO)
193:
XV. Human Experimentation and Medical Ethics, Manila, Philippines, 1981
561:
International Federation of Clinical Chemistry and Laboratory Medicine
309:; Titles marked with * are not yet published (still work in progress)
289:
Expert Working Group on MedDRA Labeling Groupings (founded April 2019)
283:
Clinical Research in Resource-Limited Settings (founded November 2017)
896:"CIOMS and ICH Initiatives in Pharmacovigilance and Risk Management"
157:
III. Evaluation of Drugs: Whose Responsibility? Liège, Belgium, 1968
444:
World Association of Societies of Pathology and Laboratory Medicine
238:
XXIX. Ethics, Equity, and Health for All, Geneva, Switzerland, 1997
140:
111:
that organized 17 conferences from 1867 until the 1913 outbreak of
1053:
26:
633:
360:
306:
144:
344:. While neither of these documents are legally binding like the
205:
XIV. Battered Children and Child Abuse, Berne, Switzerland, 1985
732:
104:
265:
Working Group VIII (founded September 2006): Signal Detection
404:
International Federation of Otorhinolaryngological Societies
187:
XIII. Economics and Health Policy, Geneva, Switzerland, 1979
1058:
Council for International Organizations of Medical Sciences
780:
Council for International Organizations of Medical Sciences
737:
Council for International Organizations of Medical Sciences
673:
Council for International Organizations of Medical Sciences
93:
Council for International Organizations of Medical Sciences
20:
Council for International Organizations of Medical Sciences
16:
International non-governmental medical science organization
668:
566:
International Federation of Medical Students' Associations
489:
Association of the Scientific Medical Societies in Germany
175:
IX. Medical Care and Society, Rio de Janeiro, Brazil, 1974
268:
Working Group IX (founded April 2010): Risk Minimization
1081:
271:
Working Group X (founded September 2010): Meta-Analysis
190:
XIV. Medical Ethics and Medical Education, Mexico, 1980
453:
European Network of Research Ethics Committees (EUREC)
429:
International Union of Basic and Clinical Pharmacology
556:
International Council for Laboratory Animal Science
154:
II. Heart Transplantation Geneva, Switzerland, 1968
83:
134:
1087:World Health Organization - Regulation and Safety
591:Medical Sciences Society of Queensland University
546:Federation of Polish Medical Organizations Abroad
262:Vaccine Pharmacovigilance (founded November 2005)
1098:
581:International Union of Microbiological Societies
893:
894:Tsintis, Panos; La Mache, Edith (2004-07-01).
369:International Organization for Standardization
352:, their role as recommended guidelines avoids
280:Drug-Induced Liver Injury (founded April 2017)
586:International Union of Physiological Sciences
531:American Society for Bioethics and Humanities
501:The Israel Academy of Sciences and Humanities
419:International Society of Pharmacoepidemiology
363:for adverse drug reactions, which shaped the
695:CIOMS: Organization, Activities, and Members
1048:
1046:
1044:
1042:
1040:
1038:
1036:
1034:
1032:
1030:
1028:
1026:
1024:
1022:
1020:
1018:
1016:
1014:
1012:
1010:
1008:
1006:
1004:
1002:
1000:
998:
996:
994:
992:
990:
988:
986:
984:
982:
980:
978:
976:
974:
972:
970:
424:International Society of Pharmacovigilance
414:International Society of Internal Medicine
25:
434:Medical Women's International Association
359:The first CIOMS working group produced a
387:
967:
1099:
571:International Medical Sciences Academy
513:South African Medical Research Council
373:European Committee for Standardization
824:
597:National Fund for Scientific Research
536:Asia Pacific Academy of Ophthalmology
799:
709:
707:
617:World Organization of Family Doctors
524:
471:Royal Academy of Medicine of Belgium
465:Bangladesh Medical Research Council
457:
13:
507:Korean Academy of Medical Sciences
495:Indian Council of Medical Research
394:International College of Angiology
14:
1133:
1075:
704:
607:World Association for Medical Law
519:Swiss Academy of Medical Sciences
912:10.2165/00002018-200427080-00004
612:World Federation of Chiropractic
483:Georgian Society of Pharmacology
409:International Rhinologic Society
377:Health Level Seven International
942:
649:Regulation of therapeutic goods
551:Good Clinical Practice Alliance
312:
305:All reports are available from
135:Round Tables and Working Groups
101:World Health Organization (WHO)
887:
818:
793:
768:
750:
725:
686:
661:
307:https://cioms.ch/publications/
109:International Medical Congress
107:in 1949 as a successor to the
1:
1112:Health sciences organizations
654:
382:
340:written by physicians of the
277:Vaccine Safety (founded 2013)
125:
7:
622:
323:UK Medical Research Council
10:
1138:
439:World Allergy Organization
602:Saudi Neonatology Society
477:Czech Medical Association
449:World Medical Association
342:World Medical Association
79:
69:
59:
49:
41:
33:
24:
800:Bird, Sheila M. (2014).
759:CIOMS Special Newsletter
274:Bioethics (founded 2011)
776:"Former Working Groups"
338:Declaration of Helsinki
321:, then director of the
1122:Pharmaceuticals policy
837:10.2307/j.ctv2tbwqd5.9
806:The James Lind Library
367:'s E2B guideline. The
327:Bradford Hill criteria
388:International Members
541:Consulta di Bioetica
319:Austin Bradford Hill
1082:CIOMS Official Site
505:Republic of Korea,
354:ethical imperialism
45:Geneva, Switzerland
21:
19:
1107:Clinical research
846:978-1-4473-6395-8
639:Pharmacovigilance
629:CIOMS/RUCAM scale
525:Associate Members
350:Oviedo Convention
346:Council of Europe
89:
88:
71:Secretary-General
1129:
1069:
1068:
1066:
1065:
1050:
965:
964:
962:
961:
946:
940:
939:
891:
885:
884:
878:
874:
872:
864:
862:
861:
822:
816:
815:
813:
812:
797:
791:
790:
788:
787:
772:
766:
765:
763:
754:
748:
747:
745:
744:
729:
723:
722:
720:
711:
702:
701:
699:
690:
684:
683:
681:
680:
665:
475:Czech Republic,
458:National Members
84:https://cioms.ch
29:
22:
18:
1137:
1136:
1132:
1131:
1130:
1128:
1127:
1126:
1097:
1096:
1078:
1073:
1072:
1063:
1061:
1054:"CIOMS Members"
1052:
1051:
968:
959:
957:
948:
947:
943:
892:
888:
876:
875:
866:
865:
859:
857:
847:
823:
819:
810:
808:
798:
794:
785:
783:
774:
773:
769:
761:
755:
751:
742:
740:
731:
730:
726:
718:
712:
705:
697:
691:
687:
678:
676:
667:
666:
662:
657:
625:
527:
460:
390:
385:
317:In March 1959,
315:
137:
128:
72:
62:
52:
17:
12:
11:
5:
1135:
1125:
1124:
1119:
1117:Medical ethics
1114:
1109:
1095:
1094:
1089:
1084:
1077:
1076:External links
1074:
1071:
1070:
966:
941:
906:(8): 509–517.
886:
855:j.ctv2tbwqd5.9
845:
817:
792:
767:
749:
724:
703:
685:
659:
658:
656:
653:
652:
651:
646:
644:Clinical trial
641:
636:
631:
624:
621:
620:
619:
614:
609:
604:
599:
594:
588:
583:
578:
573:
568:
563:
558:
553:
548:
543:
538:
533:
526:
523:
522:
521:
515:
511:South Africa,
509:
503:
497:
491:
485:
479:
473:
467:
459:
456:
455:
454:
451:
446:
441:
436:
431:
426:
421:
416:
411:
406:
401:
396:
389:
386:
384:
381:
361:reporting form
314:
311:
303:
302:
299:
296:
293:
290:
287:
284:
281:
278:
275:
272:
269:
266:
263:
260:
257:
254:
251:
248:
240:
239:
236:
233:
230:
227:
224:
221:
218:
215:
212:
209:
206:
203:
200:
197:
194:
191:
188:
185:
182:
179:
176:
173:
170:
167:
164:
161:
158:
155:
152:
136:
133:
127:
124:
87:
86:
81:
77:
76:
73:
70:
67:
66:
63:
61:Vice President
60:
57:
56:
53:
50:
47:
46:
43:
39:
38:
35:
31:
30:
15:
9:
6:
4:
3:
2:
1134:
1123:
1120:
1118:
1115:
1113:
1110:
1108:
1105:
1104:
1102:
1093:
1090:
1088:
1085:
1083:
1080:
1079:
1059:
1055:
1049:
1047:
1045:
1043:
1041:
1039:
1037:
1035:
1033:
1031:
1029:
1027:
1025:
1023:
1021:
1019:
1017:
1015:
1013:
1011:
1009:
1007:
1005:
1003:
1001:
999:
997:
995:
993:
991:
989:
987:
985:
983:
981:
979:
977:
975:
973:
971:
955:
951:
945:
937:
933:
929:
925:
921:
917:
913:
909:
905:
901:
897:
890:
882:
870:
856:
852:
848:
842:
838:
834:
830:
829:
821:
807:
803:
796:
781:
777:
771:
760:
753:
738:
734:
728:
717:
710:
708:
696:
689:
674:
670:
664:
660:
650:
647:
645:
642:
640:
637:
635:
632:
630:
627:
626:
618:
615:
613:
610:
608:
605:
603:
600:
598:
595:
592:
589:
587:
584:
582:
579:
577:
574:
572:
569:
567:
564:
562:
559:
557:
554:
552:
549:
547:
544:
542:
539:
537:
534:
532:
529:
528:
520:
517:Switzerland,
516:
514:
510:
508:
504:
502:
498:
496:
492:
490:
486:
484:
480:
478:
474:
472:
468:
466:
462:
461:
452:
450:
447:
445:
442:
440:
437:
435:
432:
430:
427:
425:
422:
420:
417:
415:
412:
410:
407:
405:
402:
400:
397:
395:
392:
391:
380:
378:
374:
370:
366:
362:
357:
355:
351:
347:
343:
339:
335:
330:
328:
324:
320:
310:
308:
300:
297:
294:
291:
288:
285:
282:
279:
276:
273:
270:
267:
264:
261:
258:
255:
252:
249:
246:
245:
244:
237:
234:
231:
228:
225:
222:
219:
216:
213:
210:
207:
204:
201:
198:
195:
192:
189:
186:
183:
180:
177:
174:
171:
168:
165:
162:
159:
156:
153:
150:
149:
148:
146:
142:
132:
123:
121:
116:
114:
110:
106:
102:
98:
94:
85:
82:
78:
74:
68:
64:
58:
55:Hervé LeLouet
54:
48:
44:
40:
36:
32:
28:
23:
1062:. Retrieved
1057:
958:. Retrieved
953:
944:
903:
899:
889:
858:. Retrieved
827:
820:
809:. Retrieved
805:
795:
784:. Retrieved
779:
770:
752:
741:. Retrieved
736:
733:"Governance"
727:
688:
677:. Retrieved
672:
663:
634:CIOMS I Form
463:Bangladesh,
358:
333:
331:
316:
313:Publications
304:
241:
138:
129:
119:
117:
96:
92:
90:
42:Headquarters
956:. June 2021
900:Drug Safety
877:|work=
375:(CEN), and
113:World War I
75:Lembit Rägo
65:Samia Hurst
1101:Categories
1064:2022-11-29
960:2022-11-30
860:2022-11-30
811:2022-11-30
786:2022-11-29
743:2022-11-29
679:2022-11-29
655:References
383:Membership
126:Governance
920:1179-1942
879:ignored (
869:cite book
764:(Report).
721:(Report).
700:(Report).
487:Germany,
481:Georgia,
469:Belgium,
51:President
34:Formation
936:23598726
928:15154824
623:See also
499:Israel,
141:Brussels
669:"About"
593:, Haiti
493:India,
371:(ISO),
145:Belgium
80:Website
1060:. 2022
934:
926:
918:
853:
843:
782:. 2022
739:. 2022
675:. 2022
932:S2CID
851:JSTOR
762:(PDF)
719:(PDF)
698:(PDF)
97:CIOMS
924:PMID
916:ISSN
881:help
841:ISBN
103:and
91:The
37:1949
908:doi
833:doi
348:'s
1103::
1056:.
969:^
952:.
930:.
922:.
914:.
904:27
902:.
898:.
873::
871:}}
867:{{
849:.
839:.
804:.
778:.
735:.
706:^
671:.
356:.
143:,
122:.
115:.
1067:.
963:.
938:.
910::
883:)
863:.
835::
814:.
789:.
746:.
682:.
95:(
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
